DEVELOPMENT OF A MEDICINAL AGENT BASED ON THE PEPTIDE ANTAGONIST OF OREXIN RECEPTOR FOR SUPPRESSION OF ALCOHOL DEPENDENCE

I V Duhovlinov , N A Klimov , E A Fedorova , Yu V Zherebcova , E A Chernyaeva , A I Orlov

Medical academic journal ›› 2017, Vol. 17 ›› Issue (2) : 42 -47.

PDF
Medical academic journal ›› 2017, Vol. 17 ›› Issue (2) : 42 -47. DOI: 10.17816/MAJ17242-47
Articles
research-article

DEVELOPMENT OF A MEDICINAL AGENT BASED ON THE PEPTIDE ANTAGONIST OF OREXIN RECEPTOR FOR SUPPRESSION OF ALCOHOL DEPENDENCE

Author information +
History +
PDF

Abstract

The aims of the research were to synthesize gene, coding previously designed artificial protein antorex - the antagonist of orexins receptor OxR1, to explore it's expression in Escherichia coli cells and to develop the process of this protein purification from Escherichia coli cell lysates. Methods of chemical and enzymatic DNA synthesis, genetic engineering, selection and chromatography were used. The gene coding antorex protein was synthesized, the plasmid DNA рЕТ-antorex, containing this gene and Escherichia coli strain BL21(pЕT-аntorex) - the stable producer of recombinant protein antorex were obtained. Methods of Escherichia coli producer strain cultivation and antorex protein purification with the use of reverse-phase and ion-exchange chromatography was developed. Large-scale cultivation of producer strain was performed in 10L fermenter and the pilot lot of 480 mg of antorex protein with the purity of 97,5% was produced. The developed methods lead to production and purification of antorex artificial protein for conducting pre-clinical and clinical trials.

Cite this article

Download citation ▾
I V Duhovlinov, N A Klimov, E A Fedorova, Yu V Zherebcova, E A Chernyaeva, A I Orlov. DEVELOPMENT OF A MEDICINAL AGENT BASED ON THE PEPTIDE ANTAGONIST OF OREXIN RECEPTOR FOR SUPPRESSION OF ALCOHOL DEPENDENCE. Medical academic journal, 2017, 17(2): 42-47 DOI:10.17816/MAJ17242-47

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Sakurai Т. Reverse pharmacology of orexin: from an orphan GPCR to integrative physiology // Regulatory peptides. 2005. Vol. 126, No 1. Р. 3-10.

[2]

DiLeone R.J., Georgescu D., Nestler E.J. Lateral hypothalamic neuropeptides in reward and drug addiction // Life Sci. 2003. Vol. 73, No 6. P. 759-768.

[3]

Paneda C., Winsky-Sommerer R., Boutrel B., de Lecea L. The corticotropin-releasing factor hypocretin connection: implications in stress response and addiction // Drug News Perspect. 2005. Vol. 18, No 4. P. 250-255.

[4]

Harris G.C., Wimmer M., Aston J.G. A role for lateral hypothalamic orexin neurons in reward seeking // Nature. 2005. Vol. 437, No 7058. P. 556-559.

[5]

Borgland S.L., Taha S.A., Sarti F., Fields H.L., Bonci A. Orexin A in the VTA is critical for the induction of synaptic plasticity and behavioral sensitization to cocaine // Neuron. 2006. Vol. 49, No 4. P. 589-601.

[6]

Pasumarthi R.K., Reznikov L.R., Fadel J. Activation of orexin neurons by acute nicotine // Eur. J. Pharmacol. 2006. Vol. 535, No 1-3. P. 172-176.

[7]

Narita M., Nagumo Y., Hashimoto S., Narita M., Khotib J., Miyatake M., Sakurai T., Yanagisawa M., Nakamachi T., Shioda S., Suzuki T. Direct involvement of orexinergic systems in the activation of the mesolimbic dopamine pathway and related behaviors induced by morphine // J. of Neurosci. 2006. Vol. 26, No 2. P. 398-405.

[8]

Majumder K. Ligation-free gene synthesis by PCR: synthesis and mutagenesis at multiple loci of a chimeric gene encoding OmpA signal peptide and hirudin // Gene. 1992. Vol. 110, No 1. P. 89-94.

[9]

Laemmly U.K. Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 // Nature. 1970. Vol. 227. P. 680-685.

[10]

Studier F.W. Stable expression clones and auto-induction for protein production in E. coli // Methods Mol Biol. 2014. Vol. 1091, No 1. P. 17-32.

RIGHTS & PERMISSIONS

Duhovlinov I.V., Klimov N.A., Fedorova E.A., Zherebcova Y.V., Chernyaeva E.A., Orlov A.I.

AI Summary AI Mindmap
PDF

131

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/